Elevance Health (ELV) Short term Debt (2009 - 2026)

Elevance Health (ELV) has 18 years of Short term Debt data on file, last reported at $724.0 million in Q1 2026.

• Short term Debt for Q1 2026 came in at $724.0 million, down 55.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $724.0 million (down 55.93% YoY), and the FY2025 annual result was $150.0 million, down 58.9% from the prior year.
• Short term Debt climbed to $724.0 million in Q1 2026 per ELV's latest filing, from $150.0 million in the prior quarter.
• Over five years, Short term Debt peaked at $2.9 billion in Q1 2024 and troughed at $150.0 million in Q4 2025.
• A 5-year average of $1.2 billion and a median of $1.1 billion in 2022 frame the typical range for Short term Debt.
• The sharpest annual moves came in 2022 and 2024: Short term Debt soared 1184.57% in 2022, then tumbled 77.87% in 2024.
• A 5-year view of Short term Debt shows it stood at $1.5 billion in 2022, then climbed by 9.93% to $1.6 billion in 2023, then plunged by 77.87% to $365.0 million in 2024, then slumped by 58.9% to $150.0 million in 2025, then surged by 382.67% to $724.0 million in 2026.
• Business Quant data shows ELV's Short term Debt at $724.0 million in Q1 2026, $150.0 million in Q4 2025, and $749.0 million in Q3 2025.